Liver-brain axis mechanism underlying central immune remodeling triggered by peripheral hepatic damage
Cellular Signalling · 2026
DOI: 10.1016/j.cellsig.2026.112626 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular Signalling, 2026. Verfasst von Xinghua Tian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Brain Sciences Research, School of Life Sciences, Henan University, Kaifeng 475004, China. Hauptthemen laut MEDLINE: Liver, Brain, Liver Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 221 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Liver dysfunction and various hepatic disorders cause neuropsychiatric abnormalities including depression, anxiety, cognitive impairment and personality changes through liver-brain axis imbalance, greatly worsening patient prognosis. The liver-brain axis acts as a bidirectional network via neural, humoral, immune and gut microbiota pathways, and its disruption dominates liver disease-related central nervous system (CNS) injury. Toxic metabolites such as bilirubin activate the transient receptor potential cation channel subfamily M member 2 (TRPM2)-spleen tyrosine kinase (SYK)-nuclear factor kappa-B (NF-κB) pathway in microglia, triggering excessive glutamatergic synapse phagocytosis in the anterior cingulate cortex (ACC) and sustained neuroinflammation with irreversible neural circuit damage. This review summarizes the pathogenesis of neuropsychiatric complications induced by liver dysfunction and liver transplantation, focusing on blood-brain barrier (BBB) disruption, systemic immune activation, neurotransmitter imbalance and resident immune cell phenotypic shifts. It clarifies four liver-brain axis regulatory pathways, highlights microglial central functions, and addresses gut-liver-brain axis crosstalk, meningeal immunity, choroid plexus barrier damage and circadian rhythm disturbance. It also concludes diagnostic biomarkers including bilirubin and fibroblast growth factor 21 (FGF21), alongside therapeutic targets covering the TRPM2-SYK-NF-κB pathway, microglial polarization and gut microbiota. This study provides a unified theoretical framework for clinical diagnosis, risk stratification and targeted treatment of liver disease-related neuropsychiatric complications, and explains CNS dysfunction mechanisms underlying metabolic dysfunction-associated steatotic liver disease (MASLD), liver cirrhosis and acute-on-chronic liver failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Brain Sciences Research, School of Life Sciences, Henan University, Kaifeng 475004, China.
- Center for Translational Neurourology, Huaihe Hospital of Henan University, Kaifeng 475004, China. Electronic address: chengxs@henu.edu.cn.
- Institute for Brain Sciences Research, School of Life Sciences, Henan University, Kaifeng 475004, China; Center for Translational Neurourology, Huaihe Hospital of Henan University, Kaifeng 475004, China. Electronic addr…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Tian, X., Ren, Y., Chen, Y., Cheng, X., & Wei, J. (2026). Liver-brain axis mechanism underlying central immune remodeling triggered by peripheral hepatic damage. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2026.112626
Vancouver
Tian X, Ren Y, Chen Y, Cheng X, Wei J. Liver-brain axis mechanism underlying central immune remodeling triggered by peripheral hepatic damage. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2026.112626
BibTeX
@article{Tian2026,
author = {Tian, Xinghua and Ren, Yuheng and Chen, Yixu and Cheng, Xiangshu and Wei, Jianshe},
title = {Liver-brain axis mechanism underlying central immune remodeling triggered by peripheral hepatic damage},
journal = {Cellular Signalling},
year = {2026},
doi = {10.1016/j.cellsig.2026.112626}
}
EUVIMED